AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca scope 3 Cat 6 — Business travel (tCO2e)
Sustainability Data Annex — Scope 3 GHG Emissions
Latest, FY2025
42
Period ended Dec 31, 2025
Change on a year earlier
+5.0%
40 in FY2024
History
4 years
Since FY2019
Sources
1
Sustainability Data Annex 2025
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scope 3 Cat 6 — Business travel (tCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 42 | +5.0% | Sustainability Data Annex 2025 ↗ |
| FY2024 | Dec 31, 2024 | 40 | +25.0% | Sustainability Data Annex 2025 ↗ |
| FY2023 | Dec 31, 2023 | 32 | – | Sustainability Data Annex 2025 ↗ |
| FY2019 | Dec 31, 2019 | 401,730 | – | Sustainability Data Annex 2025 ↗ |
Cite this data
StockData. (2026). AstraZeneca Scope 3 Cat 6 — Business travel (tCO2e), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/esg_scope3_cat6
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.